The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.03% during 2025-2033. The market is experiencing robust growth, driven by rapid technological advancements, the rising prevalence of chronic diseases, increasing demand for early diagnosis, expanding healthcare infrastructure and the growing geriatric population.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 44.5 Billion |
Market Forecast in 2033
|
USD 70.8 Billion |
Market Growth Rate 2025-2033 | 5.03% |
Increasing Prevalence of Chronic Diseases
The rising occurrence of chronic conditions like cardiovascular diseases, cancer, and diabetes is a one of the major factors propelling the medical imaging market growth. For instance, an estimated 129 million people in the United States have at least one major chronic disease. Also, about 42% have two or more, and 12% have at least five. These diseases require regular monitoring and early diagnosis to improve treatment outcomes, driving the demand for advanced imaging technologies such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and ultrasound. For example, cardiovascular diseases remain a leading cause of death across the globe, and imaging plays a pivotal role in the early detection of complications like blockages or abnormal heart functions.
Rapid Technological Advancements in Imaging Equipment
The continuous improvements in hardware, software, and integration capabilities are expanding the medical imaging market scope. Moreover, the burgeoning integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML), three-dimensional (3D) imaging, and hybrid imaging systems is fueling the market growth. In line with this, the widespread application of AI to assist radiologists in analyzing large volumes of images more quickly and with fewer errors, thus helping early disease detection and personalized treatment plans, is enhancing the market growth. Besides this, the introduction of high-definition (HD) imaging tools that provide enhanced clarity and depth in diagnostics, aiding in the identification of complex conditions, is fostering the market growth.
Growing Demand for Early Disease Detection
The increasing focus of the healthcare industry on early detection and preventive care is another major driver boosting the medical imaging market share. Early diagnosis improves the prognosis for many serious conditions and reduces the overall cost of treatment by avoiding complications that arise from delayed diagnosis. Moreover, the introduction of various awareness campaigns by governments and healthcare organizations to educate the public about the importance of regular screenings and early detection is anticipated to drive the market growth. For example, in cancer care, regular mammograms are recommended for early breast cancer detection, which significantly increases the demand for mammography imaging systems.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product, application, and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the medical imaging industry include:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | CT Scanners, X-Ray Imaging Systems, MRI Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems, Mammography Systems |
Applications Covered | Obstetrics and Gynecology Health, Orthopedics and Musculoskeletal, Neuro and Spine, Cardiovascular and Thoracic, General Imaging, Breast Health, Others |
End Users Covered | Hospitals, Diagnostic Centers, Academic Institutes and Research Organizations |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Canon Medical Systems Corporation (Canon Inc.), Carestream Health, Cubresa Inc., Esaote SpA, FUJIFILM VisualSonics Inc., GE HealthCare (General Electric Company), Hologic Inc., Koning Corporation, Koninklijke Philips N.V., Materialise NV, Mindray Medical International Limited, Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.), Siemens Healthineers AG (Siemens AG), etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global medical imaging market was valued at USD 44.5 Billion in 2024.
We expect the global medical imaging market to exhibit a CAGR of 5.03% during 2025-2033.
The rising adoption of medical imaging in various departments, such as cardiovascular and thoracic, obstetrics and gynecology, neurology, etc., for early and accurate diagnosis, understanding complications, eliminating the need for exploratory surgery, etc., is primarily driving the global medical imaging market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for numerous medical imaging systems, such as Computed Tomography (CT) scanners and Magnetic Resonance Imaging (MRI), to detect the spread of the coronavirus infection in the lungs.
Based on the product, the global medical imaging market can be divided into CT scanners, X-ray imaging systems, MRI systems, ultrasound imaging systems, nuclear imaging systems, and mammography systems. Currently, X-ray imaging systems account for the largest market share.
Based on the application, the global medical imaging market has been segregated into obstetrics and gynecology health, orthopedics and musculoskeletal, neuro and spine, cardiovascular and thoracic, general imaging, breast health, and others. Among these, cardiovascular and thoracic currently exhibits a clear dominance in the market.
Based on the end user, the global medical imaging market can be bifurcated into hospitals, diagnostic centers, and academic institutes and research organizations. Currently, hospitals hold the majority of the total market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global medical imaging market include Canon Medical Systems Corporation (Canon Inc.), Carestream Health, Cubresa Inc., Esaote SpA, FUJIFILM VisualSonics Inc., GE HealthCare (General Electric Company), Hologic Inc., Koning Corporation, Koninklijke Philips N.V., Materialise NV, Mindray Medical International Limited, Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.), and Siemens Healthineers AG (Siemens AG).